John D. Bonnet

Prognostic factors in multiple myeloma

Raymond Alexanian, Stanley P. Balcerzak, John D. Bonnet et al. · Cancer · 1975 · 233 citations

Hematological Malignancy, Bone Marrow Failure, Medicine +14

Combination chemotherapy for multiple myeloma

Raymond Alexanian, John D. Bonnet, Edmund A. Gehan et al. · Cancer · 1972 · 210 citations · Full text

Hematological Malignancy, Immunotherapy, Medicine +14

Phase III Comparison of Doxorubicin and Dacarbazine Given by Bolus Versus Infusion in Patients With Soft-Tissue Sarcomas: A Southwest Oncology Group Study

Mark M. Zalupski, Barbara Metch, S P Balcerzak et al. · JNCI Journal of the National Cancer Institute · 1991 · 170 citations

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A southwest oncology group study

William S. Dalton, John J. Crowley, Sydney S. Salmon et al. · Cancer · 1995 · 157 citations · Full text

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study.

S. E. Salmon, Arthur Haut, John D. Bonnet et al. · Journal of Clinical Oncology · 1983 · 155 citations

Hematological Malignancy, Combination Chemotherapy, Medicine +14